Different Antipsychotics Elicit Different Effects on Magnocellular Oxytocinergic and Vasopressinergic Neurons as Revealed by Fos Immunohistochemistry.
Informácie o publikácii
Zápis:
KISS, Alexander - BUNDZIKOVÁ, Jana - PIRNÍK, Zdenko - MIKKELSEN, Jens D.. Different Antipsychotics Elicit Different Effects on Magnocellular Oxytocinergic and Vasopressinergic Neurons as Revealed by Fos Immunohistochemistry. In: Journal of Neuroscience Research. 2010. ISSN 0360-4012, Vol. 88, č. 3 (2010), s. 677-685. (2010: 2.958 - IF, 156 - H-index, 3.151 - IF 5y, 1.570 - SJR, Q3 - SJR Best Q, Q2 - JCR Best Q)
Rok vydania:
2010
Kategória:
ADC - Vedecké práce v zahraničných karentovaných časopisoch
2010: 2.958 - IF, 156 - H-index, 3.151 - IF 5y, 1.570 - SJR, Q3 - SJR Best Q, Q2 - JCR Best Q
Jazyk:
anglický
Ohlasy:
2018-2018: [1] MOLLER, Morten - BUSCH, Johannes R. - JACOBSEN, Christina - LUNDEMOSE, Sissel B. - LYNNERUP, Niels - RATH, Martin F. - BANNER, Jytte. The accessory magnocellular neurosecretory system of the rostral human hypothalamus. In CELL AND TISSUE RESEARCH. ISSN 0302-766X, 2018, vol. 373, no. 2, pp. 487-498. [WoS]
2017-2017: [1] KIR, Gulay - GOZUGUL, Esra - DUSUNUR, Ayse - YUMRU, Cengiz. Syndrome of Inappropriate Secretion of Antidiuretic Hormone Due to Olanzapine Use. In JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM. ISSN 2146-6505, 2017, vol. 7, no. 3, pp. 158-160. [WoS]
2017-2017: [1] PORFIRIO, Maria-Cristina - GOMES DE ALMEIDA, Juliana Paula - STORNELLI, Maddalena - GIOVINAZZO, Silvia - PURPER-OUAKIL, Diane - MASI, Gabriele. Can melatonin prevent or improve metabolic side effects during antipsychotic treatments? In NEUROPSYCHIATRIC DISEASE AND TREATMENT. ISSN 1178-2021, 2017, vol. 13, no., pp. 2167-2174. [WoS]
2017-2017: [1] YANG, Xiudeng - TANG, Yamei - WEI, Qinling - LANG, Bing - TAO, Huai - ZHANG, Xianghui - LIU, Yong - TANG, Aiguo. Up-regulated expression of oxytocin mRNA in peripheral blood lymphocytes from first-episode schizophrenia patients. In ONCOTARGET. ISSN 1949-2553, 2017, vol. 8, no. 45, pp. 78882-78889. [WoS]
2016-2016: [1] FEIFEL, David - SHILLING, Paul D. - MACDONALD, Kai. A Review of Oxytocins Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia. In BIOLOGICAL PSYCHIATRY. ISSN 0006-3223, 2016, vol. 79, no. 3, pp. 222. [WoS]
2016-2016: [1] ROMANO, Adele - TEMPESTA, Bianca - DI BONAVENTURA, Maria Vittoria Micioni - GAETANI, Silvana. From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders. In FRONTIERS IN NEUROSCIENCE. ISSN 1662-453X, 2016, vol. 9, no., pp. [WoS]
2016-2016: [1] SHILLING, Paul D. - FEIFEL, David. Potential of Oxytocin in the Treatment of Schizophrenia. In CNS DRUGS. ISSN 1172-7047, 2016, vol. 30, no. 3, pp. 193. [WoS]
2015-2015: [1] PALASZ, Artur - ROJCZYK, Ewa. Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain. In JOURNAL OF MOLECULAR NEUROSCIENCE. ISSN 0895-8696, 2015, vol. 57, no. 3, pp. 352. [WoS]
2015-2015: [1] RICH, Megan Elizabeth - CALDWELL, Heather Kingsley. A role for oxytocin in the etiology and treatment of schizophrenia. In FRONTIERS IN ENDOCRINOLOGY. ISSN 1664-2392, 2015, vol. 6, no., pp. [WoS]
2015-2015: [1] STRAUSS, Gregory P. - KELLER, William R. - KOENIG, James I. - GOLD, James M. - FROST, Katherine H. - BUCHANAN, Robert W. Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia. In SCHIZOPHRENIA RESEARCH. ISSN 0920-9964, 2015, vol. 162, no. 1-3, pp. 47. [WoS]
2015-2015: [1] STRAUSS, Gregory P. - KELLER, William R. - KOENIG, James I. - SULLIVAN, Sara K. - GOLD, James M. - BUCHANAN, Robert W. Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia. In SCHIZOPHRENIA RESEARCH. ISSN 0920-9964, 2015, vol. 162, no. 1-3, pp. 52. [WoS]
2014-2014: [1] ROMO-NAVA, Francisco - ALVAREZ-ICAZA GONZALEZ, Deni - FRESAN-ORELLANA, Ana - SARACCO ALVAREZ, Ricardo - BECERRA-PALARS, Claudia - MORENO, Julia - ONTIVEROS URIBE, Martha P. - BERLANGA, Carlos - HEINZE, Gerhard - BUIJS, Ruud M. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. In BIPOLAR DISORDERS. ISSN 1398-5647, 2014, vol. 16, no. 4, pp. 410. [WoS]
2013-2013: [1] CHIANG, Chih-lin - LIN, Yu-Hsuan - HSIEH, Ming H. Olanzapine-Induced Hyponatremia in a Patient with Autism. In JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. ISSN 1044-5463, 2013, vol. 23, no. 10, pp. 699. [WoS]
2013-2013: [1] HUMBLE, Mats B. - UVNAS-MOBERG, Kerstin - ENGSTROM, Ingemar - BEJEROT, Susanne. Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study. In BMC PSYCHIATRY. ISSN 1471-244X, 2013, vol. 13, no., pp. [WoS]
2013-2013: [1] MILLER, Meghan - BALES, Karen L. - TAYLOR, Sandra L. - YOON, Jong - HOSTETLER, Caroline M. - CARTER, Cameron S. - SOLOMON, Marjorie. Oxytocin and Vasopressin in Children and Adolescents With Autism Spectrum Disorders: Sex Differences and Associations With Symptoms. In AUTISM RESEARCH. ISSN 1939-3792, 2013, vol. 6, no. 2, pp. 91. [WoS]
2013-2013: [1] ROVSING, Louise - RATH, Martin Fredensborg - MOLLER, Morten. Hypothalamic Neurosecretory and Circadian Vasopressinergic Neuronal Systems in the Blind Cone-Rod Homeobox Knockout Mouse (Crx(-/-)) and the 129sv Wild-Type Mouse. In JOURNAL OF COMPARATIVE NEUROLOGY. ISSN 0021-9967, 2013, vol. 521, no. 17, pp. 4061. [WoS]
2013-2013: [1] WALSS-BASS, Consuelo - FERNANDES, Joao M. - ROBERTS, David L. - SERVICE, Helena - VELLIGAN, Dawn. Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia. In SCHIZOPHRENIA RESEARCH. ISSN 0920-9964, 2013, vol. 147, no. 2-3, pp. 387. [WoS]
2012-2012: [1] MACDONALD, Kai - FEIFEL, David. Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. In ACTA NEUROPSYCHIATRICA, 2012, vol.24, no.3, 130. [WoS]
2012-2012: [1] MONTAG, C. - BROCKMANN, E.-M. - LEHMANN, A. - MÜLLER, D.J. - RUJESCU, D. - GALLINAT, J. Association between Oxytocin Receptor Gene Polymorphisms and Self-Rated 'Empathic Concern' in Schizophrenia. In PLoS ONE, 2012, vol.7, no.12. [Scopus]
2012-2012: [1] SASAYAMA, Daimei - HATTORI, Kotaro - TERAISHI, Toshiya - HORI, Hiroaki - OTA, Miho - YOSHIDA, Sumiko - ARIMA, Kunimasa - HIGUCHI, Teruhiko - AMANO, Naoji - KUNUGI, Hiroshi. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia. In SCHIZOPHRENIA RESEARCH, 2012, vol.139, no.1-3, 201. [WoS]
2012-2012: [1] ZHAO, C. - LI, M. Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity. In Pharmacology Biochemistry and Behavior, 2012, vol.103, no.2, 174-180. [Scopus]
2011-2011: [1] NETHERTON, Elisabeth - SCHATTE, Dawnelle. Potential for oxytocin use in children and adolescents with mental illness. In HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, vol.26, no.4-5, 271-281. [WoS]